News
The maternal mortality rate rose to 19 deaths per 100,000 live births, up from 18.6 the year before. The CDC counts women who ...
Dr. Marty Makary, chief of the FDA, has expressed doubts about the agency approving the COVID-19 vaccine for winter, stating ...
The potential change outlined in a statement would require all new vaccines to undergo “placebo” testing, sparking concerns ...
The U.S. Food and Drug Administration on Wednesday approved Johnson & Johnson's drug to treat a type of muscle-weakening ...
7hon MSN
Health and Human Services employees were told in March to remove 'nicknames' from email systems and signatures to comply with ...
British animal genetics company Genus on Wednesday said the U.S. Food and Drug Administration (FDA) approved its PRP gene ...
11h
Medpage Today on MSNFDA Approves Nipocalimab for Adult and Pediatric Myasthenia GravisThe FDA approved nipocalimab (Imaavy) injection to treat adults and children ages 12 and older with generalized myasthenia ...
The US Food and Drug Administration will require all new vaccines go through placebo-controlled studies before they are ...
AI is a transformational force in healthcare, but without cybersecurity as its foundation, it becomes a high-stakes gamble.
Hoagie rolls and sourdough and whole grain multigrain loaves from Upper Crust Bakery LP have all been recalled ...
The US Department of Health and Human Services said it will require that all new vaccines be tested in placebo-controlled trials before they’re licensed for use, raising urgent questions about the ...
The US Food and Drug Administration has approved nipocalimab-aahu, a new FcRn- blocking monoclonal antibody, for the treatment of generalized myasthenia gravis.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results